Moreover, the 36-month beta value for PATH is 0.87. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 20 as “hold,” and 0 as “sell.”
The public float for PATH is 415.86M and currently, short sellers hold a 5.77% of that float. On November 04, 2024, PATH’s average trading volume was 9.01M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
PATH) stock’s latest price update
The stock of UiPath Inc (NYSE: PATH) has decreased by -2.82 when compared to last closing price of 12.57. Despite this, the company has experienced a -2.12% fall in its stock price over the last five trading sessions. prnewswire.com reported 2024-11-04 that Proposed Ruling Aims to Eliminate Out-of-Pocket Costs for Contraception, Enhancing Access for Women in the United States ADELAIDE, Australia and RALEIGH, N.C., Nov. 4, 2024 /PRNewswire/ — Mayne Pharma Group Limited (Mayne Pharma or the Company) (ASX: MYX), welcomes the Biden-Harris Administration’s newly proposed rule to expand coverage of affordable contraception under the Affordable Care Act (ACA).
PATH’s Market Performance
UiPath Inc (PATH) has experienced a -2.12% fall in stock performance for the past week, with a -2.20% drop in the past month, and a 12.17% rise in the past quarter. The volatility ratio for the week is 2.74%, and the volatility levels for the past 30 days are at 2.87% for PATH. The simple moving average for the last 20 days is -2.91% for PATH stock, with a simple moving average of -26.45% for the last 200 days.
Analysts’ Opinion of PATH
Many brokerage firms have already submitted their reports for PATH stocks, with Macquarie repeating the rating for PATH by listing it as a “Neutral.” The predicted price for PATH in the upcoming period, according to Macquarie is $12 based on the research report published on June 03, 2024 of the current year 2024.
Truist gave a rating of “Hold” to PATH, setting the target price at $14 in the report published on May 30th of the current year.
PATH Trading at -2.47% from the 50-Day Moving Average
After a stumble in the market that brought PATH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.17% of loss for the given period.
Volatility was left at 2.87%, however, over the last 30 days, the volatility rate increased by 2.74%, as shares sank -1.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.97% lower at present.
During the last 5 trading sessions, PATH fell by -2.52%, which changed the moving average for the period of 200-days by -45.28% in comparison to the 20-day moving average, which settled at $12.58. In addition, UiPath Inc saw -50.83% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PATH starting from HITESH RAMANI, who proposed sale 25,000 shares at the price of $12.33 back on Oct 03 ’24. After this action, HITESH RAMANI now owns shares of UiPath Inc, valued at $308,250 using the latest closing price.
ASHIM A GUPTA, the Officer of UiPath Inc, proposed sale 47,227 shares at $12.33 during a trade that took place back on Oct 03 ’24, which means that ASHIM A GUPTA is holding shares at $582,309 based on the most recent closing price.
Stock Fundamentals for PATH
Current profitability levels for the company are sitting at:
- -0.13 for the present operating margin
- 0.84 for the gross margin
The net margin for UiPath Inc stands at -0.08. The total capital return value is set at -0.09. Equity return is now at value -5.89, with -4.19 for asset returns.
Based on UiPath Inc (PATH), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 4.04. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is -9.97.
Currently, EBITDA for the company is -139.5 million with net debt to EBITDA at 5.47. When we switch over and look at the enterprise to sales, we see a ratio of 4.26. The receivables turnover for the company is 3.71for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.47.
Conclusion
To wrap up, the performance of UiPath Inc (PATH) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
